US Diplomat Nikki Haley Blasts China, Russia For 'Holding The Hand' Of North Korean Leader

Agencies
July 6, 2017

Washington, Jul 6: The top U.S. diplomat to the United Nations blasted Russia and China on Wednesday for "holding the hand" of North Korean leader Kim Jong Un, as the Trump administration struggled to respond to Pyongyang's latest ballistic-missile test.nikki

U.N. Ambassador Nikki Haley chided Moscow and Beijing over their opposition to a Security Council resolution condemning North Korea and imposing greater economic sanctions for what she called its "sharp military escalation."

She also said Pyongyang was "quickly closing off the possibility of a diplomatic solution" and suggested the United States would continue to consider military action if necessary.

"One of our capabilities lies with our considerable military forces," Haley said during a Security Council meeting in New York. "We will use them if we must, but we prefer not to have to go in that direction."

Haley's pointed speech marked the latest effort by the Trump administration to rally allies and rivals around a common agenda to blunt North Korea's progress, days after Kim's regime tested an intercontinental ballistic missile with a range that experts said would put it within reach of Alaska.

But her remarks also illustrated the limits of the White House's options and lacked specifics about what concrete steps the administration is considering. The missile test marks a new level of advancement in Kim's pursuit of a nuclear weapon that could strike the continental United States. Analysts said a military confrontation could escalate quickly into a mass-casualty war on the Korean Peninsula and Japan, where the United States has stationed tens of thousands of troops.

The standoff cast a shadow as President Donald Trump prepared for his first meeting with Russian President Vladimir Putin and his second with Chinese President Xi Jinping on the sidelines of the Group of 20 summit, which opens Friday in Hamburg. Trump also will meet with Japanese Prime Minister Shinzo Abe and the heads of U.S. allies Britain and Germany.

"We've been pretty consistent that we are never going to broadcast next steps," deputy White House press secretary Sarah Huckabee Sanders told reporters aboard Air Force One as the president traveled to a short stop in Warsaw on Wednesday.

Before leaving Washington, Trump revealed more frustration with Xi, whom he has personally lobbied to enact sanctions on Chinese banks that do business with North Korean companies. The U.S. Treasury Department announced last week that it would block the Bank of Dandong, along the border region between China and North Korea, from accessing U.S. markets. Officials said was the first of potentially greater sanctions by the United States.

On Twitter, Trump wrote: "Trade between China and North Korea grew almost 40% in the first quarter. So much for China working with us - but we had to give it a try!"

Chinese data released in April showed China's trade with the North grew 37.4 percent during the first three months of the year compared with the same period in 2016. China said then that overall trade grew even as it complied with U.N. sanctions and stopped buying North Korean coal.

Russian and Chinese diplomats used the U.N. Security Council meeting to push their joint proposal for a suspension of North Korean nuclear and missile testing in exchange for a suspension of U.S. and South Korean military exercises. Both countries also condemned the U.S. antimissile system being deployed in South Korea and called for it to be removed.

Early Wednesday in Asia, U.S. and South Korean forces fired missiles, conducting joint military exercises that the U.S. Pacific Command cast as a show of "ironclad" resolve.

Daniel Pinkston, a lecturer in international relations at Troy University in Seoul, said he saw no chance Washington and Seoul would agree to halt joint exercises, calling it "a non-starter."

During the U.N. meeting, a Russian official questioned whether North Korea's missile was an ICBM, suggesting it was an intermediate-range weapon.

That prompted Haley to request a second turn at the microphone, during which she said: "If you see this as a threat, if you see this for what it is, which is North Korea showing its muscle, then you need to stand strong. If you chose not to, we will go our own path."

Danny Russel, who served as senior Asia director at the National Security Council under President Barack Obama, said Trump has a "rare blue moon" opportunity this week to meet with and rally the major players - China and Russia on one side and Japan and South Korea on the other - toward some sort of unified display of condemnation of North Korea.

"What the administration needs to do is get China and Russia around an approach, even if it is not as testosterone-rich and muscular as the U.S. would like, so that the basic geometry is five on one, not three on three," said Russel, now a diplomat in residence at the Asia Society in New York. "There is no formula, no path forward, other than war, that isn't built on some degree of common cause between Washington and Beijing."

Victor Cha, who served as senior Asia director at the NSC under President George W. Bush, said the U.S. sanctions on the Dandong bank were "a shot across the bow at the Chinese that what is happening is not working for us. It arguably gives [Trump] a stronger position going in" to the meeting with Xi.

The missile the Kim regime launched had been in the works for years. It flew higher and remained in the air longer than previous attempts, in what experts called a milestone for North Korea

South Korean authorities described North Korea's test as a two-stage missile with a range of about 4,300 to 5,000 miles - enough to reach Alaska and other parts of North America.

South Korean Defense Minister Han Min-koo said there is high probability that Pyongyang will stage another nuclear test and noted gains in its efforts to miniaturize a warhead - steps toward developing nuclear-tipped weapons capable of hitting the mainland United States.

Pyongyang's test appeared to catch the United States by surprise. The Pentagon initially mislabeled the activity as a test of an intermediate-range missile before reclassifying it Wednesday as an ICBM with a range of at least 5,500 kilometers.

Navy Capt. Jeff Davis, a Pentagon spokesman, said that the missile "is not one we have seen before" and that it was launched from a site - the Panghyon airfield about 90 miles north of Pyongyang - that has not been used to test missiles before.

He emphasized that North Korea still has a number of steps to meet before a threat to North America is imminent, noting that Pyongyang has not yet demonstrated the ability to mount a nuclear warhead on a ICBM or show the lateral range necessary.

"But clearly, they are working on it," he said.

North Korea successfully test fired an intercontinental ballistic missile July 3. The missile was launched into a steep arc sending it more than 1,700 vertical miles up before beginning its reentry into Earth's atmosphere.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 6,2020

Beijing, Mar 6: World health officials have warned that countries are not taking the coronavirus crisis seriously enough, as outbreaks surged across Europe and in the United States where medical workers sounded warnings over a "disturbing" lack of hospital preparedness.

The World Health Organization warned Thursday that a "long list" of countries were not showing "the level of political commitment" needed to "match the level of the threat we all face".

"This is not a drill," WHO chief Tedros Adhanom Ghebreyesus told reporters.

"This epidemic is a threat for every country, rich and poor."

Tedros called on the heads of government in every country to take charge of the response and "coordinate all sectors", rather than leaving it to health ministries.

What is needed, he said, is "aggressive preparedness."

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 6,2020

New York, Mar 6: A 23-year-old Indian with a student visa in the US has pleaded guilty to sexual enticement of a minor girl, prosecutors have said.

Sachin Aji Bhaskar faces a maximum penalty of life in prison.

He pleaded guilty before Senior US District Judge William M Skretny to sexual enticement of a minor.

The charge carries a minimum penalty of 10 years in prison, a maximum penalty of life in prison, a fine of USD 250,000 or both, US Attorney James P Kennedy said.

Prosecutors alleged that Bhaskar communicated by text and email with an 11-year-old girl for the purpose of engaging in sexual activity.

Through those communications, Bhaskar enticed the victim to engage in a sexual activity with him in August, 2018, they said.

The sentencing in the case is scheduled for June 17.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
August 7,2020

Russia boasts that it's about to become the first country to approve a Covid-19 vaccine, with mass vaccinations planned as early as October using shots that are yet to complete clinical trials -- and scientists worldwide are sounding the alarm that the headlong rush could backfire.

Moscow sees a Sputnik-like propaganda victory, recalling the Soviet Union's launch of the world's first satellite in 1957.

But the experimental Covid-19 shots began first-in-human testing on a few dozen people less than two months ago, and there's no published scientific evidence yet backing Russia's late entry to the global vaccine race, much less explaining why it should be considered a front-runner.

“I'm worried that Russia is cutting corners so that the vaccine that will come out may be not just ineffective, but also unsafe,” said Lawrence Gostin, a global public health law expert at Georgetown University. “It doesn't work that way... Trials come first. That's really important.”

According to Kirill Dmitriev, head of Russia's Direct Investment Fund that bankrolled the effort, a vaccine developed by the Gamaleya research institute in Moscow may be approved in days, before scientists complete what's called a Phase 3 study.

That final-stage study, usually involving tens of thousands of people, is the only way to prove if an experimental vaccine is safe and really works.

Health Minister Mikhail Murashko said members of “risk groups,” such as medical workers, may be offered the vaccine this month.

He didn't clarify whether they would be part of the Phase 3 study that is said to be completed after the vaccine receives “conditional approval.”

Deputy Prime Minister Tatyana Golikova promised to start “industrial production” in September, and Murashko said mass vaccination may begin as early as October.

Dr Anthony Fauci, the top US infectious disease specialist, questioned the fast-track approach last week.

“I do hope that the Chinese and the Russians are actually testing a vaccine before they are administering the vaccine to anyone, because claims of having a vaccine ready to distribute before you do testing I think is problematic at best," he said.

Questions about this vaccine candidate come after the US, Britain and Canada last month accused Russia of using hackers to steal vaccine research from Western labs.

Delivering a vaccine first is a matter of national prestige for the Kremlin as it tries to assert the image of Russia as a global power capable of competing with the US and China.

The notion of being “the first in the world” dominated state news coverage of the effort, with government officials praising reports of the first-step testing.

In April, President Vladimir Putin ordered state officials to shorten the time of clinical trials for a variety of drugs, including potential coronavirus vaccines.

According to Russia's Association of Clinical Trials Organizations, the order set “an unattainable bar” for scientists who, as a result, "joined in on the mad race, hoping to please those at power.”

The association first raised concern in late May, when professor Alexander Gintsburg, head of the Gamaleya institute, said he and other researchers tried the vaccine on themselves.

The move was a “crude violation of the very foundations of clinical research, Russian law and universally accepted international regulations" the group said in an open letter to the government, urging scientists and health officials to adhere to clinical research standards.

But a month later, the Health Ministry authorized clinical trials of the Gamaleya product, with what appeared to be another ethical issue.

Human studies started June 17 among 76 volunteers. Half were injected with a vaccine in liquid form and the other half with a vaccine that came as soluble powder.

Some in the first half were recruited from the military, which raised concerns that servicemen may have been pressured to participate.

Some experts said their desire to perform well would affect the findings. “It's no coincidence media reports we see about the trials among the military said no one had any side effects, while the (other group) reported some," said Vasily Vlassov, a public health expert with Moscow's Higher School of Economics.

As the trials were declared completed and looming regulatory approval was announced last week, questions arose about the vaccine's safety and effectiveness.

Government assurances the drug produced the desired immune response and caused no significant side effects were hardly convincing without published scientific data describing the findings.

The World Health Organization said all vaccine candidates should go through full stages of testing before being rolled out.

“There are established practices and there are guidelines out,” WHO spokesman Christian Lindmeier said Tuesday.

“Between finding or having a clue of maybe having a vaccine that works, and having gone through all the stages, is a big difference.”

Offering an unsafe compound to medical workers on the front lines of the outbreak could make things worse, Georgetown's Gostin said, adding: “What if the vaccine started killing them or making them very ill?”

Vaccines that are not properly tested can cause harm in many ways — from a negative impact on health to creating a false sense of security or undermining trust in vaccinations, said Thomas Bollyky, director of the global health program at the Council on Foreign Relations. 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.